Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis lesion segmentation using dictionary learning and sparse coding.
MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: No.
Intensive care unit admission in multiple sclerosis: Increased incidence and increased mortality.
Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.
Fingolimod Reduces Direct Medical Costs Compared to Natalizumab in Patients with Relapsing-Remitting Multiple Sclerosis in the Netherlands.
Multi-slice myelin water imaging for practical clinical applications at 3.0 T.
Dietary interventions for multiple sclerosis.
Sunshine and multiple sclerosis.
Driving performance in persons with mild to moderate symptoms of multiple sclerosis.
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation.
Association of Cerebrospinal Fluid Levels of Lateral Olfactory Tract Usher Substance (LOTUS) With Disease Activity in Multiple Sclerosis.
Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective.
The human papillomavirus vaccination is not associated with risk of multiple sclerosis or other demyelinating diseases.
Tysabri Review Launched in Europe
Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study.
Activity-dependent regulation of excitable axonal domains.
The effect of group psycho-education program on the burden of family caregivers with multiple sclerosis patients in Isfahan in 2013-2014.
Fine-tuning of type I IFN-signaling in microglia - implications for homeostasis, CNS autoimmunity and interferonopathies.
Long-term efficacy of Gilenya® reinforced by new 'no evidence of disease activity' (NEDA-4) analysis in MS patients over seven years
Contribution of genome-wide association studies to scientific research: a pragmatic approach to evaluate their impact.
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.
Carbon Monoxide and the Brain : Time to Rethink the Dogma.
Prognostic factors of acute partial transverse myelitis-reply.
Understanding tremor in multiple sclerosis: prevalence, pathological anatomy, and pharmacological and surgical approaches to treatment.
Cognitive deficits in pediatric-onset multiple sclerosis: what does the future hold?
Pages
« first
‹ previous
…
385
386
387
388
389
390
391
392
393
…
next ›
last »